Christopher Brett Primiano, EVP, CBO, GC & Secretary at Karyopharm Therapeutics Inc. (KPTI), sold 772 shares at $14.92 ($12K) on 2020-11-02, disclosed to the SEC on 2020-11-04.
Scheduled sale ($12k) by EVP, CBO, GC & Secretary under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| KPTI | SELL | 2020-09-10 | $301K | — | Filing → |
| KPTI | SELL | 2020-05-11 | $322K | — | Filing → |
| KPTI | SELL | 2020-03-04 | $672K | — | Filing → |